HMA Managing Principal Anne Winter joined the “Our American States” podcast, produced by the National Conference of State Legislatures, to discuss emerging gene therapies and the high costs associated with them. The episode, The Fiscal Challenge of Emerging Gene Therapies, originally aired Jan. 11, 2021.
Anne, an expert in state Medicaid policy and pharmacy benefit management, discussed how states are tackling the high cost of these treatments and finding ways to fund these new gene therapies which can offer life-changing treatment for patients with some cancers and other rare disorders. She discussed a recent state Medicaid pharmacy director survey which revealed utilization and costs for these drugs of most concern. In addition, she highlighted some of the strategies specific states are implementing in order to fund these therapies and treatments.